Biogen (BIIB) Current Assets (2009 - 2026)

Biogen has reported Current Assets for 18 years, with the latest figure at $7.3 billion in Q2 2026.

• On a quarterly basis, Current Assets fell 8.31% year-over-year to $7.3 billion in Q2 2026; TTM through Jun 2026 was $7.3 billion, a 8.31% decrease from a year earlier, with the FY2025 full-year figure at $9.0 billion, up 20.35% from the prior year.
• Current Assets was $7.3 billion for Q2 2026 at Biogen, down from $9.2 billion in the prior quarter.
• The five-year high for Current Assets was $10.4 billion in Q2 2023, with the low at $6.8 billion in Q1 2024.
• Average Current Assets over 5 years is $8.4 billion, with a median of $8.2 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Current Assets soared 36.35% in 2022, then slumped 31.86% in 2024.
• Over 5 years, Current Assets stood at $9.8 billion in 2022, then dropped by 29.94% to $6.9 billion in 2023, then increased by 8.71% to $7.5 billion in 2024, then advanced by 20.35% to $9.0 billion in 2025, then fell by 18.59% to $7.3 billion in 2026.
• The last three Current Assets figures came in at $7.3 billion (Q2 2026), $9.2 billion (Q1 2026), and $9.0 billion (Q4 2025), per Business Quant data.